Clinical Trials and Case Studies

Next-Generation Tumor Profiling Identified High Total Mutation Burden (TMB) in Lymphoepithelioma-Like Carcinoma of the Urinary Bladder (LELCB): A Potential Rationale for Immunotherapy

– Jue Wang